20 May 2014
UK-based biopharmaceutical business Kymab has picked up $40m through a Series B financing round from the Bill & Melinda Gates Foundation and existing backer the Wellcome Trust.
Read full story
The outlook for infrastructure private equity and venture industry - from the latest AltAssets' LP-GP Forum
Private equity has delivered – yet most LPs are way below the allocation of top performers like Yale. Should more LPs be playing the long game and committing more to alternative asset classes?
AltAssets is registered as a trademark of Investor Networks Limited (06695690).Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJContent is © AltAssets 2000-2016